The authors determined the stress/strain characteristics of basal and marginal mitral valve chordae tendineae. The chordae exhibit a nonlinear stress/strain behavior typical of biologic materials, with a discrete transition in the tensile elastic modulus. The post-transition moduli for both basal and marginal chordae are greater than the pretransition values by a factor of approximately 10. In addition, the stress carried by the marginal chordae is higher than that supported by the basal ones at all recorded strains, indicating the marginal chordae are stiffer than the basal chordae. The authors determined the number and distribution of chordal insertions, and found a marginal to basal insertion ratio of almost 2 to 1. The implication is that it may be possible surgically to remove basal chordae without seriously compromising mitral valve function.
Download full-text PDF |
Source |
---|
Hum Reprod
December 2024
Assisted Reproduction Center, Northwest Women's and Children's Hospital, Xi'an, China.
Study Question: Are live birth rates (LBRs) per woman following flexible progestin-primed ovarian stimulation (fPPOS) treatment non-inferior to LBRs per woman following the conventional GnRH-antagonist protocol in expected suboptimal responders undergoing freeze-all cycles in assisted reproduction treatment?
Summary Answer: In women expected to have a suboptimal response, the 12-month likelihood of live birth with the fPPOS treatment did not achieve the non-inferiority criteria when compared to the standard GnRH antagonist protocol for IVF/ICSI treatment with a freeze-all strategy.
What Is Known Already: The standard PPOS protocol is effective for ovarian stimulation, where medroxyprogesterone acetate (MPA) is conventionally administered in the early follicular phase for ovulatory suppression. Recent retrospective cohort studies on donor cycles have shown the potential to prevent premature ovulation and maintain oocyte yields by delaying the administration of MPA until the midcycle (referred to as fPPOS), similar to GnRH antagonist injections.
Plant Dis
December 2024
Chiang Mai University, Biology, Room 2410/00, SCB2 building, Faculty of Science, Chiang Mai University,239 Huay Kaew Road, Suthep, Muang, Chiang Mai Province, Thailand, 50200;
Peacock plant (Calathea orbifolia (Linden) H.A.Kenn.
View Article and Find Full Text PDFIntegr Cancer Ther
December 2024
Department of Surgery, College of Medicine, Taif University, Taif, Saudi Arabia.
Background: Breast cancer is a critical threat to human health, and effective targeted agents showing lower systemic toxicity are still lacking. Therefore, exploring new potent therapeutic candidates with a broader safety margin is warranted. Alternative medicine, which has historically been used in traditional Chinese medicine, has played an increasingly prominent role in this area of research.
View Article and Find Full Text PDFFront Plant Sci
December 2024
Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, China.
(Asteraceae), a new species of , is described and illustrated from Lushan in Sichuan, Southwest China. Its systematic position is evaluated based on a molecular phylogenetic analysis of the nuclear ribosomal and on morphological comparison with related species. It is morphologically similar to and , with purplish red abaxially leaves.
View Article and Find Full Text PDFSemin Plast Surg
November 2024
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
Mohs micrographic surgery (MMS) is a tissue-sparing skin cancer resection technique that involves 100% margin analysis. This procedure is performed in the outpatient setting under local anesthesia by dermatologic surgeons who act as both the surgeon and the pathologist. The technique allows for prompt reconstruction immediately after cancer clearance and offers the highest cure rate for many skin malignancies, including basal and squamous cell carcinoma, as well as more rare tumors.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!